Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1589 USD | +0.57% | -2.93% | -26.50% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 39.63M |
---|---|---|---|---|---|
Net income 2024 * | -25M | Net income 2025 * | -34M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.59
x | P/E ratio 2025 * |
-1.44
x | Employees | 32 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.47% |
Latest transcript on Matinas BioPharma Holdings, Inc.
1 day | +0.57% | ||
1 week | -2.93% | ||
Current month | -2.93% | ||
1 month | -7.08% | ||
3 months | -38.65% | ||
6 months | -33.04% | ||
Current year | -26.50% |
Managers | Title | Age | Since |
---|---|---|---|
Jerome Jabbour
FOU | Founder | 50 | 13-04-30 |
Keith Kucinski
DFI | Director of Finance/CFO | 55 | 19-01-02 |
Hui Liu
CTO | Chief Tech/Sci/R&D Officer | 56 | 20-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Herbert Conrad
FOU | Founder | 91 | 13-04-30 |
Natasha Giordano
BRD | Director/Board Member | 62 | 20-09-13 |
Eric Ende
CHM | Chairman | 55 | 17-04-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 0.1589 | +0.57% | 424,570 |
24-06-06 | 0.158 | -1.86% | 466,112 |
24-06-05 | 0.161 | +2.94% | 667,317 |
24-06-04 | 0.1564 | -1.88% | 930,686 |
24-06-03 | 0.1594 | -2.63% | 889,938 |
Delayed Quote Nyse, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.50% | 39.63M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.57B | |
+3.23% | 22.82B | |
-10.44% | 18.19B | |
-41.74% | 16.54B | |
-13.31% | 16.5B | |
+2.44% | 13.39B | |
+27.89% | 11.1B |
- Stock Market
- Equities
- MTNB Stock